Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors.

Chief Medical Officer Helen Collins sold 5,000 shares of common stock on May 18, 2026 for approximately $199,000 at an average price of $39.79 per share. The article is a routine insider transaction disclosure with no accompanying operational or financial update. Market impact is likely minimal unless part of a broader pattern of insider selling.

Analysis

Chief Medical Officer Helen Collins sold 5,000 shares of common stock on May 18, 2026 for approximately $199,000 at an average price of $39.79 per share. The article is a routine insider transaction disclosure with no accompanying operational or financial update. Market impact is likely minimal unless part of a broader pattern of insider selling.